Sources | Names Used |
---|---|
CTRPv2 | Compound 1541A |
PharmacoGx | Compound 1541A |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | KNSTRN | CTRPv2 | pan-cancer | AAC | -0.1 | 0.009 |
mRNA | RBPJ | CTRPv2 | pan-cancer | AAC | 0.1 | 0.01 |
mRNA | ZNF329 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.01 |
mRNA | TAB2 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.01 |
mRNA | XPOT | CTRPv2 | pan-cancer | AAC | 0.1 | 0.01 |
mRNA | CD164 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.01 |
mRNA | RNF38 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.01 |
mRNA | ARG2 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.01 |
mRNA | SRRM3 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.01 |
mRNA | C19orf67 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.01 |